HOUSTON, Feb. 10 /PRNewswire-FirstCall/ -- Cyberonics, Inc. today announced that senior management will be presenting at the Smith Barney Citigroup 2005 Small & Mid-Cap Conference on Thursday, February 17, 2005 at 9:25 AM PST at The Four Seasons Hotel in Las Vegas. Robert P. (“Skip”) Cummins, Cyberonics’ Chairman and Chief Executive Officer, will make the presentation. Pamela B. Westbrook, Vice President Finance and Administration and Chief Financial Officer will be available for Q&A.
Pamela B. Westbrook, Vice President of Finance and Administration and Chief Financial Officer commented, “We expect that the FDA approvable decision of our TRD Expedited Review PMA-Supplement and Amendment that we received last week will ultimately transform Cyberonics and the entire neuromodulation industry. We intend to provide ample opportunities for investors and analysts to interact with Cyberonics senior management over the next few months to promote well-informed investment decisions going forward. Cyberonics will be presenting at several conferences over the next few months, including the Citigroup Small and Midcap conference, the SG Cowen conference in Boston in March and the Morgan Stanley small cap conference in New York in June. We expect to release the results for Q4 and fiscal 2005 along with guidance for FY06 and our revised 5 year business outlook in June 2005. Immediately following that release, we plan to host a Cyberonics and Neuromodulation investor and analyst day at Cyberonics headquarters in Houston.”
Presentation slides for the Smith Barney Citigroup Conference will be available on-line at http://www.cyberonics.com/ beginning Thursday, February 17, 2005 at 8:00 AM EST. Smith Barney Citigroup will host a webcast of the presentation live and by replay at http://www.veracast.com/webcasts/sbcitigroup/smc05/33203107.aspx or by going to http://www.cyberonics.com/ and clicking on the link for this webcast. The replay of the webcast will be available for 30 days following the presentation. Access to the webcast and webcast replay is not protected by a password.
ABOUT VNS THERAPY AND CYBERONICS
Cyberonics, Inc. was founded in 1987 to design, develop and market medical devices for the long-term treatment of epilepsy and other chronic neurological disorders using a unique therapy, vagus nerve stimulation (VNS). Stimulation is delivered by the VNS Therapy System, an implantable generator similar to a cardiac pacemaker. The VNS Therapy System delivers preprogrammed intermittent mild electrical pulses to the vagus nerve 24 hours a day. The Company’s initial market is epilepsy, which is characterized by recurrent seizures. Epilepsy is the second most prevalent neurological disorder. The Cyberonics VNS Therapy System was approved by the FDA on July 16, 1997 for use as an adjunctive therapy in reducing the frequency of seizures in adults and adolescents over 12 years of age with partial onset seizures that are refractory to antiepileptic medications. The VNS Therapy System is also approved for sale as a treatment for epilepsy in all the member countries of the European Economic Area, Canada, Australia and other markets. To date, more than 28,000 epilepsy patients in 24 countries have accumulated over 79,000 patient years of experience using VNS Therapy. The VNS Therapy System is approved for sale in the European Economic Area and in Canada as a treatment for depression in patients with treatment-resistant or treatment- intolerant major depressive episodes including unipolar depression and bipolar disorder (manic depression). VNS Therapy is at various levels of investigational clinical study as a potential treatment for depression, anxiety disorders, Alzheimer’s disease, and chronic headache/migraine. The Company is headquartered in Houston, Texas and has an office in Brussels, Belgium. For additional information please visit us at http://www.cyberonics.com/ .
Cyberonics, Inc.
CONTACT: Pamela B. Westbrook, Vice President of Finance and CFO ofCyberonics, Inc., +1-281-228-7200, or fax, +1-281-218-9332, orpbw@cyberonics.com ; or Helen Shik, Vice President of Schwartz Communications,+1-781-684-0770, or fax, +1-781-684-6500, or hshik@schwartz-pr.com , forCyberonics, Inc.
